dc.contributor.author |
Hoteit R. |
dc.contributor.author |
Taher A. |
dc.contributor.author |
Nassar R. |
dc.contributor.author |
Otrock Z. |
dc.contributor.author |
Halawi R. |
dc.contributor.author |
Mahfouz R.A.R. |
dc.contributor.editor |
|
dc.date |
Mar-2012 |
dc.date.accessioned |
2017-10-05T15:59:33Z |
dc.date.available |
2017-10-05T15:59:33Z |
dc.date.issued |
2012 |
dc.identifier |
10.1089/gtmb.2011.0114 |
dc.identifier.isbn |
|
dc.identifier.issn |
19450265 |
dc.identifier.uri |
http://hdl.handle.net/10938/19075 |
dc.description.abstract |
Aim: Molecular diagnostics has markedly improved the diagnosis and workup of different clinical conditions including hypercoagulable state or thrombophilia where different genes are involved. In this report, which is the largest report in the medical literature and the first in Lebanon, we describe the prevalence of simultaneous mutations in the three major thrombophilia genes Factor V, Factor II, and methylenetetrahydrofolate reductase. Materials and Methods: Using a polymerase chain reaction and reverse hybridization assay for the corresponding mutations identification, 2248 referred cases were analyzed. Results: Only 25 cases were found to be simultaneously positive for the three mutations at a prevalence rate of 1.1percent. Conclusion: Compared with other populations, this prevalence rate is considered high, possibly the highest, and warrants future clinical studies and follow-up. © Copyright 2012, Mary Ann Liebert, Inc.. |
dc.format.extent |
|
dc.format.extent |
Pages: (223-225) |
dc.language |
English |
dc.publisher |
NEW ROCHELLE |
dc.relation.ispartof |
Publication Name: Genetic Testing and Molecular Biomarkers; Publication Year: 2012; Volume: 16; no. 3; Pages: (223-225); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Frequency of triple mutations involving factor V, prothrombin, and methylenetetrahydrofolate reductase genes among patients referred for molecular thrombophilia workup in a tertiary care center in Lebanon |
dc.type |
Article |
dc.contributor.affiliation |
Hoteit, R., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon |
dc.contributor.affiliation |
Taher, A., Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon |
dc.contributor.affiliation |
Nassar, R., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon |
dc.contributor.affiliation |
Otrock, Z., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon |
dc.contributor.affiliation |
Halawi, R., Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon |
dc.contributor.affiliation |
Mahfouz, R.A.R., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon |
dc.contributor.authorAddress |
Mahfouz, R.A.R.; Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon; email: rm11@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pathology and Laboratory Medicine; |
dc.contributor.authorDepartment |
Pathology and Laboratory Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
rm11@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Hoteit, R |
dc.contributor.authorInitials |
Taher, A |
dc.contributor.authorInitials |
Nassar, R |
dc.contributor.authorInitials |
Otrock, Z |
dc.contributor.authorInitials |
Halawi, R |
dc.contributor.authorInitials |
Mahfouz, RAR |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Mahfouz, RAR (reprint author), AUBMC, Dept Pathol and Lab Med, POB 11-0236, Beirut 11072020, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Arslan S, 2011, MOL BIOL REP, V38, P2395, DOI 10.1007-s11033-010-0373-y; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Bourouba R, 2009, CLIN APPL THROMB-HEM, V15, P529, DOI 10.1177-1076029608319944; Caramaschi P, 2010, JOINT BONE SPINE, V77, P330, DOI 10.1016-j.jbspin.2010.02.022; Duga S, 2004, INT J BIOCHEM CELL B, V36, P1393, DOI 10.1016-j.biocel.2003.08.002; Ehrenforth S, 1999, ARTERIOSCL THROM VAS, V19, P276; Ehrenforth S, 1998, BLOOD, V91, P2209; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; Jayandharan G, 2005, J THROMB HAEMOST, V3, P1446, DOI 10.1111-j.1538-7836.2005.01402.x; Kfoury E, 2009, MOL BIOL REP, V36, P1041, DOI 10.1007-s11033-008-9278-4; Makris M, 1997, THROMB HAEMOSTASIS, V78, P1426; Margaglione M, 1999, THROMB HAEMOSTASIS, V82, P1583; Mozafari H, 2009, MOL BIOL REP, V36, P2361, DOI 10.1007-s11033-009-9458-x; Otrock ZK, 2008, ANN HEMATOL, V87, P1013, DOI 10.1007-s00277-008-0543-3; Rahimi Z, 2011, MOL BIOL REP, V38, P2117, DOI 10.1007-s11033-010-0338-1; Rahimi Z, 2011, MOL BIOL REP, V38, P703, DOI 10.1007-s11033-010-0157-4; Sabbagh A, 2009, MOL BIOL REP, V36, P399, DOI 10.1007-s11033-007-9193-0; Sabbagh AS, 2008, GENET TEST, V12, P75, DOI 10.1089-gte.2007.0064; Said JM, 2010, OBSTET GYNECOL, V115, P5, DOI 10.1097-AOG.0b013e3181c68907; Severinsen MT, 2010, BRIT J HAEMATOL, V149, P273, DOI 10.1111-j.1365-2141.2010.08086.x; Simioni P, 2000, BLOOD, V96, P3329; Spiroski I, 2008, CROAT MED J, V49, P39, DOI 10.3325-cmj.2008.1.39; Taher A, 2001, THROMB HAEMOSTASIS, V86, P723; Tatarskyy P, 2010, Tsitol Genet, V44, P3; Zahed LF, 2006, AM J OBSTET GYNECOL, V195, P1114, DOI 10.1016-j.ajog.2006.06.082; Zoller B, 1998, BLOOD, V91, P2210 |
dc.description.citedCount |
2 |
dc.description.citedTotWOSCount |
1 |
dc.description.citedWOSCount |
1 |
dc.format.extentCount |
3 |
dc.identifier.articleNo |
|
dc.identifier.coden |
|
dc.identifier.pubmedID |
22023246 |
dc.identifier.scopusID |
84858802263 |
dc.identifier.url |
|
dc.publisher.address |
140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Genet. Test. Mol. Biomark. |
dc.relation.ispartOfIssue |
3 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Genetic Testing and Molecular Biomarkers |
dc.relation.ispartofPubTitleAbbr |
Gent. Test. and Mol. Biomarkers |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
16 |
dc.source.ID |
WOS:000301777000014 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
|
dc.subject.otherChemCAS |
blood clotting factor 5, 9001-24-5, 9013-23-4 |
dc.subject.otherChemCAS |
methylenetetrahydrofolate reductase (NADPH2), 71822-25-8 |
dc.subject.otherChemCAS |
prothrombin, 9001-26-7 |
dc.subject.otherChemCAS |
Factor V, 9001-24-5 |
dc.subject.otherChemCAS |
MTHFR protein, human, 1.5.1.20 |
dc.subject.otherChemCAS |
Methylenetetrahydrofolate Reductase (NADPH2), 1.5.1.20 |
dc.subject.otherChemCAS |
Prothrombin, 9001-26-7 |
dc.subject.otherIndex |
blood clotting factor 5 |
dc.subject.otherIndex |
methylenetetrahydrofolate reductase (NADPH2) |
dc.subject.otherIndex |
prothrombin |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
gene frequency |
dc.subject.otherIndex |
gene mutation |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
human tissue |
dc.subject.otherIndex |
hybridization |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
medical literature |
dc.subject.otherIndex |
molecular genetics |
dc.subject.otherIndex |
polymerase chain reaction |
dc.subject.otherIndex |
tertiary health care |
dc.subject.otherIndex |
thrombophilia |
dc.subject.otherIndex |
Academic Medical Centers |
dc.subject.otherIndex |
Asian Continental Ancestry Group |
dc.subject.otherIndex |
Factor V |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Gene Frequency |
dc.subject.otherIndex |
Genetic Predisposition to Disease |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Methylenetetrahydrofolate Reductase (NADPH2) |
dc.subject.otherIndex |
Mutation |
dc.subject.otherIndex |
Polymerase Chain Reaction |
dc.subject.otherIndex |
Prevalence |
dc.subject.otherIndex |
Prothrombin |
dc.subject.otherIndex |
Referral and Consultation |
dc.subject.otherIndex |
Risk Factors |
dc.subject.otherIndex |
Thrombophilia |
dc.subject.otherKeywordPlus |
DEEP VENOUS THROMBOSIS |
dc.subject.otherKeywordPlus |
INHERITED THROMBOPHILIA |
dc.subject.otherKeywordPlus |
PREGNANCY OUTCOMES |
dc.subject.otherKeywordPlus |
HIGH PREVALENCE |
dc.subject.otherKeywordPlus |
GLN MUTATION |
dc.subject.otherKeywordPlus |
ARG 506 |
dc.subject.otherKeywordPlus |
THROMBOEMBOLISM |
dc.subject.otherKeywordPlus |
LEIDEN |
dc.subject.otherKeywordPlus |
RISK |
dc.subject.otherKeywordPlus |
CARRIERS |
dc.subject.otherWOS |
Biochemistry and Molecular Biology |
dc.subject.otherWOS |
Genetics and Heredity |